BASF increases cash offer for Pronova BioPharma
date:Jan 17, 2013
stake indirectly controlled by investment firms Kistefos AS and Kistefos Investment AS, and 0.3% held by members of the Board of Directors and management of Pronova.
BASF expects closing of the offer in the first quarter of 2013.